Standard Biotools (LAB) EBT Margin (2010 - 2026)
Standard Biotools (LAB) reported EBT Margin of 69.11% for Q1 2026, up 4704.0% year-over-year from 1.44% in Q1 2025, and down 135.37% on a QoQ basis from 195.42% in Q4 2025.
Standard Biotools (LAB) has 17 years of EBT Margin data on file, last reported at 69.11% in Q1 2026.
- Quarterly EBT Margin rose 4704.0% year-over-year to 69.11% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 22.37% (up 1274.0% YoY) and the FY2025 annual result came in at 33.01%, down 637.0% from the prior year.
- EBT Margin declined to 69.11% in Q1 2026 per LAB's latest filing, from 195.42% in the prior quarter.
- Across five years, EBT Margin topped out at 195.42% in Q4 2025 and bottomed at 346.98% in Q2 2022.
- The 5-year median for EBT Margin is 82.58% (2023), against an average of 74.3%.
- The widest annual swing landed in 2022, when EBT Margin slumped 29004 bps; it then jumped 28647 bps in 2023.
- Tracing LAB's EBT Margin over 5 years: stood at 6.99% in 2022, then soared by 1148 bps to 73.25% in 2023, then surged by 116 bps to 158.4% in 2024, then advanced by 23 bps to 195.42% in 2025, then slumped by 135 bps to 69.11% in 2026.
- Per Business Quant, the three latest LAB EBT Margin figures stand at 69.11% (Q1 2026), 195.42% (Q4 2025), and 168.27% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn | -69.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.11% |
| Dec 31, 2025 | 195.42% |
| Sep 30, 2025 | -168.27% |
| Jun 30, 2025 | -84.01% |
| Mar 31, 2025 | -116.16% |
| Dec 31, 2024 | 158.40% |
| Sep 30, 2024 | -98.71% |
| Jun 30, 2024 | -112.95% |
| Mar 31, 2024 | -70.33% |
| Dec 31, 2023 | 73.25% |
| Sep 30, 2023 | -82.58% |
| Jun 30, 2023 | -60.50% |
| Mar 31, 2023 | -66.01% |
| Dec 31, 2022 | -6.99% |
| Sep 30, 2022 | -117.52% |
| Jun 30, 2022 | -346.98% |
| Mar 31, 2022 | -290.00% |
| Sep 30, 2021 | -53.55% |
| Jun 30, 2021 | -56.93% |
| Mar 31, 2021 | -62.49% |
| Dec 31, 2020 | -38.20% |
| Sep 30, 2020 | -15.66% |
| Jun 30, 2020 | -54.34% |
| Mar 31, 2020 | -537.42% |
| Dec 31, 2019 | -38.01% |
| Sep 30, 2019 | -53.05% |
| Jun 30, 2019 | -52.83% |
| Mar 31, 2019 | -84.43% |
| Dec 31, 2018 | -46.45% |
| Sep 30, 2018 | -53.62% |
| Jun 30, 2018 | -62.23% |
| Mar 31, 2018 | -57.15% |
| Dec 31, 2017 | -37.40% |
| Sep 30, 2017 | -67.40% |
| Jun 30, 2017 | -74.27% |
| Mar 31, 2017 | -74.34% |
| Dec 31, 2016 | -78.91% |
| Sep 30, 2016 | -90.57% |
| Jun 30, 2016 | -69.72% |
| Mar 31, 2016 | -71.19% |
| Dec 31, 2015 | -42.59% |
| Sep 30, 2015 | -33.62% |
| Jun 30, 2015 | -54.17% |
| Mar 31, 2015 | -62.01% |
| Dec 31, 2014 | -35.33% |
| Sep 30, 2014 | -48.95% |
| Jun 30, 2014 | -50.02% |
| Mar 31, 2014 | -68.25% |
| Dec 31, 2013 | -22.03% |
| Sep 30, 2013 | -23.21% |
| Jun 30, 2013 | -23.06% |
| Mar 31, 2013 | -24.17% |
| Dec 31, 2012 | -22.78% |
| Sep 30, 2012 | -32.01% |
| Jun 30, 2012 | -35.36% |
| Mar 31, 2012 | -60.77% |
| Dec 31, 2011 | -26.32% |
| Sep 30, 2011 | -42.18% |
| Jun 30, 2011 | -67.36% |
| Mar 31, 2011 | -83.82% |
| Dec 31, 2010 | -32.75% |
| Sep 30, 2010 | -815.63% |
| Jun 30, 2010 | -58.31% |